Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended November 30, 2022
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission File Number: 001-35992
Oracle Corporation
(Exact name of registrant as specified in its charter)
Delaware
54-2185193
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
2300 Oracle Way
Austin, Texas
78741
(Address of principal executive offices)
(Zip Code)
(737) 867-1000
(Registrant s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
3.125% senior notes due July 2025
ORCL
New York Stock Exchange
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
The number of shares of registrant s common stock outstanding as of December 7, 2022 was: 2,696,253,000.
Table of Contents
ORACLE CORPORATION
FORM 10-Q QUARTERLY REPORT
TABLE OF CONTENTS
Page
PART I.
FINANCIAL INFORMATION
Item 1.
Financial Statements (Unaudited)
Condensed Consolidated Balance Sheets as of November 30, 2022 and May 31, 2022
Condensed Consolidated Statements of Operations for the Three and Six Months Ended November 30, 2022 and 2021
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Six Months Ended November 30, 2022 and 2021
Condensed Consolidated Statements of Stockholders Deficit for the Three and Six Months Ended November 30, 2022 and 2021
Condensed Consolidated Statements of Cash Flows for the Six Months Ended November 30, 2022 and 2021
Notes to Condensed Consolidated Financial Statements
Item 2.
Management s Discussion and Analysis of Financial Condition and Results of Operations
27
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
45
Item 4.
Controls and Procedures
45
PART II.
OTHER INFORMATION
47
Item 1.
Legal Proceedings
47
Item 1A.
Risk Factors
47
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
47
Item 6.
Exhibits
48
Signatures
49
Table of Contents
Cautionary Note on Forward-Looking Statements
For purposes of this Quarterly Report, the terms Oracle, we, us and our refer to Oracle Corporation and its consolidated subsidiaries. This Quarterly Report on Form 10-Q contains statements that are not historical in nature, are predictive in nature, or that depend upon or refer to future events or conditions or otherwise contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act), and Section 27A of the Securities Act of 1933, as amended (Securities Act). These include, among other things, statements regarding:
our expectations regarding the impacts on our business as a result of the global COVID-19 pandemic
our expectation that we may acquire, and realize the anticipated benefits of acquiring, companies, products, services and technologies to further our corporate strategy as compelling opportunities become available
our expectation that, on a constant currency basis, our total cloud and license revenues generally will continue to increase due to expected growth in our cloud services and license support offerings, and continued demand for our cloud license and on-premise license offerings
our expectation that substantially all of our customers will renew their license support contracts annually
our expectation that our hardware business will have lower operating margins as a percentage of revenues than our cloud and license business
our expectation that we will continue to make significant investments in research and development, and our belief that research and development efforts are essential to maintaining our competitive position
our expectation that our international operations will continue to provide a significant portion of our total revenues and expenses
our expectation that variable expenditures that were curtailed primarily in response to COVID-19 may normalize in future periods provided global economic and health conditions improve
our expectation that the proportion of our cloud services revenues relative to our total revenues will continue to increase
the sufficiency of our sources of funding for working capital, capital expenditures, contractual obligations, acquisitions, dividends, stock repurchases, debt repayments and other matters
our belief that we have adequately provided under U.S. generally accepted accounting principles for outcomes related to our tax audits and that the final outcome of our tax-related examinations, agreements or judicial proceedings will not have a material effect on our results of operations, and our belief that our net deferred tax assets will likely be realized in the foreseeable future
our belief that the outcome of certain legal proceedings and claims to which we are a party will not, individually or in the aggregate, result in losses that are materially in excess of amounts already recognized, if any
our expectation that certain litigation related charges and other expenses will not recur
the possibility that certain legal proceedings to which we are a party could have a material impact on our financial position or results of operations
the timing and amount of expenses we expect to incur
the cost savings we expect to realize pursuant to our Fiscal 2022 Oracle Restructuring Plan
Table of Contents
declarations of future cash dividend payments and the timing and amount of future stock repurchases, including our expectation that the levels of our future stock repurchase activity may be modified in comparison to past periods in order to use available cash for other purposes
our expectations regarding the impact of recent accounting pronouncements on our consolidated financial statements
our ability to predict revenues, particularly certain cloud license and on-premise license revenues and hardware revenues
the percentages of remaining performance obligations that we expect to recognize as revenues over respective future periods
as well as other statements regarding our future operations, financial condition and prospects, and business strategies. Forward-looking statements may be preceded by, followed by or include the words expects, anticipates, intends, plans, believes, seeks, strives, endeavors, estimates, will, should, is designed to and similar expressions. We claim the protection of the safe harbor for forward-looking statements contained in the Exchange Act and the Securities Act for all forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to risks, uncertainties and assumptions about our business that could affect our future results and could cause those results or other outcomes to differ materially from those expressed or implied in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in Risk Factors included in documents we file from time to time with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for our fiscal year ended May 31, 2022 and our other Quarterly Reports on Form 10-Q to be filed by us in our fiscal 2023, which runs from June 1, 2022 to May 31, 2023.
We have no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or risks, except to the extent required by applicable securities laws. If we do update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. New information, future events or risks could cause the forward-looking events we discuss in this Quarterly Report not to occur. You should not place undue reliance on these forward-looking statements, which reflect our expectations only as of the date of this Quarterly Report.
Table of Contents
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements (Unaudited)
ORACLE CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
As of November 30, 2022 and May 31, 2022
(Unaudited)
(in millions, except per share data)
November 30,
2022
May 31,
2022
ASSETS
Current assets:
Cash and cash equivalents
6,813
21,383
Marketable securities
537
519
Trade receivables, net of allowances for credit losses of $403 and $362 as of November 30, 2022 and May 31, 2022, respectively
6,197
5,953
Prepaid expenses and other current assets
4,014
3,778
Total current assets
17,561
31,633
Non-current assets:
Property, plant and equipment, net
14,351
9,716
Intangible assets, net
11,593
1,440
Goodwill, net
61,513
43,811
Deferred tax assets
12,091
12,782
Other non-current assets
11,360
9,915
Total non-current assets
110,908
77,664
Total assets
128,469
109,297
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Notes payable and other borrowings, current
9,746
3,749
Accounts payable
1,647
1,317
Accrued compensation and related benefits
1,780
1,944
Deferred revenues
8,705
8,357
Other current liabilities
5,228
4,144
Total current liabilities
27,106
19,511
Non-current liabilities:
Notes payable and other borrowings, non-current
81,173
72,110
Income taxes payable
11,128
12,210
Deferred tax liabilities
7,165
6,031
Other non-current liabilities
5,673
5,203
Total non-current liabilities
105,139
95,554
Commitments and contingencies
Oracle Corporation stockholders' deficit:
Preferred stock, $0.01 par value authorized: 1.0 shares outstanding: none
Common stock, $0.01 par value and additional paid in capital authorized: 11,000 shares outstanding: 2,695 shares and 2,665 shares as of November 30, 2022 and May 31, 2022, respectively
28,148
26,808
Accumulated deficit
(30,617
(31,336
Accumulated other comprehensive loss
(1,777
(1,692
Total Oracle Corporation stockholders' deficit
(4,246
(6,220
Noncontrolling interests
470
452
Total stockholders' deficit
(3,776
(5,768
Total liabilities and stockholders' deficit
128,469
109,297
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three and Six Months Ended November 30, 2022 and 2021
(Unaudited)
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions, except per share data)
2022
2021
2022
2021
Revenues:
Cloud services and license support
8,598
7,554
17,015
14,925
Cloud license and on-premise license
1,435
1,237
2,339
2,049
Hardware
850
767
1,613
1,530
Services
1,392
802
2,753
1,583
Total revenues
12,275
10,360
23,720
20,087
Operating expenses:
Cloud services and license support(1)
1,891
1,259
3,626
2,472
Hardware(1)
286
229
536
474
Services(1)
1,181
671
2,233
1,315
Sales and marketing(1)
2,216
1,954
4,393
3,808
Research and development
2,158
1,754
4,251
3,438
General and administrative
366
319
777
618
Amortization of intangible assets
907
299
1,826
603
Acquisition related and other
62
4,667
103
4,687
Restructuring
137
32
281
70
Total operating expenses
9,204
11,184
18,026
17,485
Operating income (loss)
3,071
(824
5,694
2,602
Interest expense
(856
(679
(1,643
(1,384
Non-operating (expenses) income, net
(71
(251
(34
Income (loss) before income taxes
2,144
(1,496
3,800
1,184
(Provision for) benefit from income taxes
(403
249
(511
25
Net income (loss)
1,741
(1,247
3,289
1,209
Earnings (loss) per share:
Basic
0.65
(0.46
1.22
0.44
Diluted
0.63
(0.46
1.20
0.43
Weighted average common shares outstanding:
Basic
2,695
2,694
2,690
2,731
Diluted
2,746
2,694
2,747
2,823
(1)
Exclusive of amortization of intangible assets, which is shown separately.
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
For the Three and Six Months Ended November 30, 2022 and 2021
(Unaudited)
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions)
2022
2021
2022
2021
Net income (loss)
1,741
(1,247
3,289
1,209
Other comprehensive income (loss), net of tax:
Net foreign currency translation gains (losses)
95
(222
(194
(445
Net unrealized gains (losses) on defined benefit plans
(1
Net unrealized gains on cash flow hedges
93
110
Total other comprehensive income (loss), net
188
(220
(85
(441
Comprehensive income (loss)
1,929
(1,467
3,204
768
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS DEFICIT
For the Three and Six Months Ended November 30, 2022 and 2021
(Unaudited)
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions, except per share data)
2022
2021
2022
2021
Common stock and additional paid in capital
Balance, beginning of period
27,224
25,534
26,808
26,533
Common stock issued
146
157
661
305
Stock-based compensation
909
681
1,659
1,226
Repurchases of common stock
(61
(711
(134
(1,583
Other, net
(70
(70
(846
(890
Balance, end of period
28,148
25,591
28,148
25,591
Accumulated deficit
Balance, beginning of period
(31,134
(25,679
(31,336
(20,120
Repurchases of common stock
(361
(6,289
(847
(13,417
Cash dividends declared
(863
(861
(1,723
(1,748
Net income (loss)
1,741
(1,247
3,289
1,209
Balance, end of period
(30,617
(34,076
(30,617
(34,076
Other stockholders' deficit, net
Balance, beginning of period
(1,539
(985
(1,240
(461
Other comprehensive income (loss), net
188
(220
(85
(441
Other, net
44
32
18
(271
Balance, end of period
(1,307
(1,173
(1,307
(1,173
Total stockholders' deficit
(3,776
(9,658
(3,776
(9,658
Cash dividends declared per common share
0.32
0.32
0.64
0.64
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Six Months Ended November 30, 2022 and 2021
(Unaudited)
Six Months Ended
November 30,
(in millions)
2022
2021
Cash flows from operating activities:
Net income
3,289
1,209
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
1,138
913
Amortization of intangible assets
1,826
603
Deferred income taxes
(852
(820
Stock-based compensation
1,659
1,226
Other, net
289
(176
Changes in operating assets and liabilities, net of effects from acquisitions:
Decrease in trade receivables, net
516
789
Decrease in prepaid expenses and other assets
121
263
Decrease in accounts payable and other liabilities
(785
(918
Decrease in income taxes payable
(327
(849
Increase (decrease) in deferred revenues
369
(531
Net cash provided by operating activities
7,243
1,709
Cash flows from investing activities:
Purchases of marketable securities and other investments
(603
(9,631
Proceeds from sales and maturities of marketable securities and other investments
462
21,617
Acquisitions, net of cash acquired
(27,799
(50
Capital expenditures
(4,154
(1,987
Net cash (used for) provided by investing activities
(32,094
9,949
Cash flows from financing activities:
Payments for repurchases of common stock
(1,000
(15,001
Proceeds from issuances of common stock
661
305
Shares repurchased for tax withholdings upon vesting of restricted stock-based awards
(895
(890
Payments of dividends to stockholders
(1,723
(1,748
Proceeds from issuances of commercial paper, net of repayments
1,880
Proceeds from issuances of senior notes and other borrowings, net of issuance costs
28,280
Repayments of senior notes and other borrowings
(16,692
(5,750
Other, net
(56
(437
Net cash provided by (used for) financing activities
10,455
(23,521
Effect of exchange rate changes on cash and cash equivalents
(174
(297
Net decrease in cash and cash equivalents
(14,570
(12,160
Cash and cash equivalents at beginning of period
21,383
30,098
Cash and cash equivalents at end of period
6,813
17,938
Non-cash financing activities:
Fair values of stock awards assumed in connection with acquisitions
55
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
November 30, 2022
(Unaudited)
1.
BASIS OF PRESENTATION, RECENT ACCOUNTING PRONOUNCEMENTS AND OTHER
Basis of Presentation
We have prepared the condensed consolidated financial statements included herein pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures herein are adequate to ensure the information presented is not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2022.
The comparability of our condensed consolidated financial statements during the second quarter and first half of fiscal 2023 compared to the corresponding prior year periods was impacted by $4.7 billion of certain litigation related charges during the fiscal 2022 periods presented. Refer to Note 16 to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended May 31, 2022 for additional information.
On June 8, 2022, we completed our acquisition of Cerner Corporation (Cerner), a provider of digital information systems used within hospitals and health systems, by means of a merger of one of our wholly owned subsidiaries with and into Cerner such that Cerner became an indirect, wholly owned subsidiary of Oracle. Through our acquisition of Cerner, we enhanced our offerings of each of our three existing businesses, cloud and license, hardware and services. The condensed consolidated financial statements included in this Quarterly Report include the financial results of Cerner prospectively from the date of acquisition. Refer to Note 2 below for additional details regarding our acquisition of Cerner.
We believe that all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for our fiscal year ending May 31, 2023.
There have been no changes to our significant accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended May 31, 2022 that had a significant impact on our condensed consolidated financial statements or notes thereto as of and for the six months ended November 30, 2022.
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
November 30, 2022
(Unaudited)
Use of Estimates
Our condensed consolidated financial statements are prepared in accordance with GAAP as set forth in the Financial Accounting Standards Board s (FASB) Accounting Standards Codification, and we consider various staff accounting bulletins and other applicable guidance issued by the SEC. These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent that there are differences between these estimates, judgments or assumptions and actual results, our consolidated financial statements will be affected. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management s judgment in its application. There are also areas in which management s judgment in selecting among available alternatives would not produce a materially different result.
During the first quarter of fiscal 2023, we completed an assessment of the useful lives of our servers and increased the estimate of the useful lives from four years to five years effective at the beginning of fiscal 2023. Based on the carrying value of our servers as of May 31, 2022, this change in accounting estimate decreased our total operating expenses by $114 million and $245 million for the second quarter and first half of fiscal 2023, respectively.
Cash, Cash Equivalents and Restricted Cash
Restricted cash that was included within cash and cash equivalents as presented within our condensed consolidated balance sheets as of November 30, 2022 and May 31, 2022 and our condensed consolidated statements of cash flows for the six months ended November 30, 2022 and 2021 was nominal.
Remaining Performance Obligations from Contracts with Customers
Trade receivables, net of allowance for credit losses, and deferred revenues are reported net of related uncollected deferred revenues in our condensed consolidated balance sheets as of November 30, 2022 and May 31, 2022. The revenues recognized during the six months ended November 30, 2022 and 2021, respectively, that were included in the opening deferred revenues balances as of May 31, 2022 and 2021, respectively, were approximately $6.2 billion and $6.5 billion, respectively. Revenues recognized from performance obligations satisfied in prior periods and impairment losses recognized on our receivables were immaterial in each of the three and six months ended November 30, 2022 and 2021, respectively.
Remaining performance obligations, as defined in Note 1 of Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2022, were $61.2 billion as of November 30, 2022, approximately 48% of which we expect to recognize as revenues over the next twelve months, 35% over the subsequent month 13 to month 36, and the remainder thereafter.
Sales of Financing Receivables
We offer certain of our customers the option to acquire certain of our cloud and license, hardware and services offerings through separate long-term payment contracts. We generally sell these contracts that we have financed for our customers on a non-recourse basis to financial institutions within 90 days of the contracts dates of execution. We record the transfers of amounts due from customers to financial institutions as sales of financing receivables because we are considered to have surrendered control of these financing receivables. Financing receivables sold to financial institutions were $265 million and $1.2 billion for the three and six months ended November 30, 2022, respectively, and $351 million and $1.0 billion for the three and six months ended November 30, 2021, respectively.
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
November 30, 2022
(Unaudited)
Non-Marketable Investments
Our non-marketable debt investments and equity securities and related instruments totaled $2.0 billion and $1.2 billion as of November 30, 2022 and May 31, 2022, respectively, and are included in other non-current assets in the accompanying consolidated balance sheets and are subject to periodic impairment reviews. Certain of these non-marketable equity securities and related instruments are adjusted for observable price changes from orderly transactions. The majority of the non-marketable investments held as of these dates were with a related party entity for which we follow the equity method of accounting. We are also a counterparty to certain options to acquire additional equity interests in that entity at various times through June 2025 and we could obtain control of that entity should such options be exercised.
Acquisition Related and Other Expenses
Acquisition related and other expenses primarily consist of personnel related costs for transitional and certain other employees, certain business combination adjustments, including adjustments after the measurement period has ended, and certain other operating items, net. For the fiscal 2022 periods presented, acquisition related and other expenses included certain litigation related charges.
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions)
2022
2021
2022
2021
Transitional and other employee related costs
21
38
Business combination adjustments, net
Other, net
38
4,664
57
4,679
Total acquisition related and other expenses
62
4,667
103
4,687
Non-Operating (Expenses) Income, net
Non-operating (expenses) income, net consists primarily of interest income, net foreign currency exchange losses, the noncontrolling interests in the net profits of our majority-owned subsidiaries (primarily Oracle Financial Services Software Limited and Oracle Corporation Japan), net gains and losses related to equity investments including losses attributable to equity method investments and net other income and expenses, including net unrealized gains and losses from our investment portfolio related to our deferred compensation plan, and non-service net periodic pension income and losses.
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions)
2022
2021
2022
2021
Interest income
52
21
90
40
Foreign currency losses, net
(55
(46
(125
(81
Noncontrolling interests in income
(41
(42
(79
(89
(Losses) gains from equity investments, net
(40
80
(126
59
Other gains (losses), net
13
(6
(11
37
Total non-operating (expenses) income, net
(71
(251
(34
10
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
November 30, 2022
(Unaudited)
Recent Accounting Pronouncements
Financial Instruments: In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04) and also issued subsequent amendments to the initial guidance (collectively, Topic 848). Topic 848 provides optional guidance for contract modifications and certain hedging relationships associated with the transition from reference rates that are expected to be discontinued. We will adopt Topic 848 when our relevant contracts are modified upon transition to alternative reference rates. We do not expect our adoption of Topic 848 to have a material impact on our consolidated financial statements.
2.
ACQUISITIONS
Acquisition of Cerner Corporation
On December 20, 2021, we entered into an Agreement and Plan of Merger (Merger Agreement) with Cerner, a provider of digital information systems used within hospitals and health systems that are designed to enable medical professionals to deliver better healthcare to individual patients and communities.
On January 19, 2022, pursuant to the Merger Agreement, we commenced a tender offer to purchase all of the issued and outstanding shares of common stock of Cerner at a purchase price of $95.00 per share, net to the seller in cash, without interest thereon, based upon the terms and subject to the conditions set forth in the Offer to Purchase dated January 19, 2022, and the related Letter of Transmittal.
On June 8, 2022, pursuant to the terms of the tender offer and applicable Delaware law, we acquired all the outstanding Cerner shares and effectuated the merger of Cerner with and into a wholly-owned subsidiary of Oracle and Cerner became an indirect, wholly-owned subsidiary of Oracle. Vested equity awards outstanding immediately prior to the consummation of the merger were cancelled in exchange for the right to receive an amount in cash based on a formula contained in the Merger Agreement. The unvested equity awards to acquire Cerner common stock that were outstanding immediately prior to the conclusion of the merger were converted into equity awards denominated in shares of Oracle common stock based on formulas contained in the Merger Agreement. We have included the financial results of Cerner in our consolidated financial statements from the date of acquisition. For the second quarter and first half of fiscal 2023, Cerner contributed $1.5 billion and $3.0 billion to our total revenues, respectively.
The total preliminary purchase price for Cerner was approximately $28.2 billion, which consisted of approximately $28.2 billion in cash and $55 million for the fair values of restricted stock-based awards and stock options assumed. Pursuant to our business combinations accounting policy, we estimated the preliminary fair values of net tangible and intangible assets acquired, and the excess of the consideration transferred over the aggregate of such fair values was recorded as goodwill. The preliminary fair values of net tangible assets and intangible assets acquired were based on preliminary valuations, and our estimates and assumptions are subject to change within the measurement period (up to one year from the acquisition date). The primary areas that remain preliminary relate to the fair values of intangible assets acquired, certain tangible assets and liabilities acquired, certain legal matters, income and non-income based taxes and residual goodwill. We expect to continue to obtain information to assist us in determining the fair values of the net assets acquired during the measurement period. The following table summarizes the estimated preliminary fair values of net tangible and intangible assets acquired from Cerner:
11
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
November 30, 2022
(Unaudited)
(in millions)
Cash and marketable securities
769
Trade receivables, net
843
Property, plant and equipment, net
1,514
Intangible assets
11,972
Goodwill
17,777
Other assets
837
Accounts payable and other liabilities
(979
Deferred revenues
(297
Senior notes and other borrowings
(1,600
Deferred tax liabilities, net
(2,611
Total
28,225
All of the $1.6 billion of senior notes and other borrowings assumed through our Cerner acquisition were paid during the first half of fiscal 2023. Refer to Note 5 below for more information. We do not expect the goodwill recognized as a part of our acquisition of Cerner to be deductible for income tax purposes.
Other Fiscal 2023 and 2022 Acquisitions
During the first half of fiscal 2023 and full year fiscal 2022, we acquired certain other companies and purchased certain technology and development assets primarily to expand our products and services offerings. These acquisitions were not significant individually or in the aggregate to our condensed consolidated financial statements.
Unaudited Pro Forma Financial Information
The unaudited pro forma financial information in the table below summarizes the combined results of operations for Oracle and Cerner. The unaudited pro forma financial information for all periods presented included the business combination accounting effects resulting from this acquisition, including amortization charges from acquired intangible assets (certain of which are preliminary), stock-based compensation charges for unvested restricted stock-based awards and stock options assumed and the related tax effects as though Cerner was combined as of the beginning of fiscal 2022. The unaudited pro forma financial information as presented below is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of fiscal 2022.
The unaudited pro forma financial information for the three and six months ended November 30, 2022 and 2021 combined the historical results of Oracle for the three and six months ended November 30, 2022 and 2021, respectively, the historical results of Cerner for the three and six months ended September 30, 2022 and 2021, respectively, (adjusted due to differences in reporting periods and considering the date we acquired Cerner) and the effects of the pro forma adjustments listed above. The unaudited pro forma financial information was as follows: